Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.

Heavy metals might contribute to hair loss in Telogen Effluvium.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

Biotin deficiency is not a major cause of Telogen Effluvium hair loss.

Thyroid problems are linked to various skin issues, and checking thyroid health is important for people with certain skin conditions.

Both Unani treatments effectively reduced hair shedding in Telogen Effluvium.

COVID-19 infection may cause hair loss.

Iron deficiency anemia may contribute to hair loss in women with Telogen effluvium.

Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Finasteride slightly better long-term, minoxidil faster initial results, but stopping minoxidil may cause hair loss.

COVID-19 may trigger sudden temporary hair loss.

Alitretinoin may cause irreversible hair curling as a side effect.

Patients with systemic lupus erythematosus and hair loss had non-scarring alopecia with fewer hair follicles, and direct immunofluorescence did not help identify lupus.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

A new hair loss classification for women improves treatment, but careful patient selection is crucial for successful hair transplantation.

Thyroid disorders are linked to skin conditions like vitiligo and hair loss, so thyroid tests are recommended.

Careful planning and technique in upper facial rejuvenation can minimize risks like hair loss, nerve damage, and scarring.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

COVID-19 may cause hair loss by affecting hair follicles.

The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Low iron and vitamin D3 levels might be major causes of hair loss in Iraqi women.

Telogen Effluvium causes more hair loss because hair moves to the resting phase too soon.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

South Korean women with hair loss have lower hair density and thickness compared to healthy women.